Concepedia

Author

H Lambert

Hammersmith Hospital

Also Known As

H E Lambert, H Lambert, H. E. Lambert, H. Lambert, H.E Lambert, H.E. LAMBERT, H.E. Lambert, Hanna Lambert, Hannah E. Lambert, Hannah Lambert

72

Publications

2.2K

Citations

21

H-Index

51

Concepts

All Affiliations

Hammersmith HospitalMount Vernon HospitalCharing Cross HospitalKing Edward VII Hospital
HL

About

H Lambert is an author at Hammersmith Hospital specializing in medicine, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

17

1.3K

2

Health Sciences

6

6

419

3

Public Health

2

2

23

4

Immunology

2

2

233

5

Biomedical Engineering

1

1

11

H Lambert

×

26

Publications

2.1K

Citations

21

H-Index

YearCitations

Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125.

G.J.S. Rustin, Ann E. Nelstrop, Patrick McClean,

Journal of Clinical Oncology

1996

377

Defining progression of ovarian carcinoma during follow-up according to CA 125: A North Thames Ovary Group study

G.J.S. Rustin, Ann E. Nelstrop, Malgorzata Tuxen,

Annals of Oncology

1996

284

Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies.

A. A. Epenetos, Alastair J. Munro, Simon Stewart,

Journal of Clinical Oncology

1987

204

Surgical clips in planning the electron boost in breast cancer: A qualitative and quantitative evaluation

Kevin J. Harrington, Mark Harrison, Patricia Bayle,

International Journal of Radiation Oncology*Biology*Physics

1996

124

A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinoma

H Lambert, G.J.S. Rustin, Walter M. Gregory,

Annals of Oncology

1997

121

Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer.

John S. Stewart, V Hird, D Snook,

Journal of Clinical Oncology

1990

120

Intraperitoneal radioimmunotherapy for ovarian cancer: Pharmacokinetics, toxicity, and efficacy of I-131 labeled monoclonal antibodies

J.S.W. Stewart, V Hird, D Snook,

International Journal of Radiation Oncology*Biology*Physics

1989

107

Long term survival of patients with advanced ovarian cancer treated with intraperitoneal radioimmunotherapy

Agamemnon A. Epenetos, V Hird, H Lambert,

International Journal of Gynecological Cancer

2000

103

Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysis.

Steve Nicholson, Calvin S. R. Gooden, V Hird,

Oncology Reports

1998

83

A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group study.

H Lambert, G.J.S. Rustin, Walter M. Gregory,

Journal of Clinical Oncology

1993

82

Page 1